Anti‐donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? MD Griffin, AE Ryan, S Alagesan, P Lohan, O Treacy, T Ritter Immunology and cell biology 91 (1), 40-51, 2013 | 295 | 2013 |
Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy? S Alagesan, MD Griffin Current opinion in organ transplantation 19 (1), 65-72, 2014 | 94 | 2014 |
Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis D Cigognini, D Gaspar, P Kumar, A Satyam, S Alagesan, C Sanz-Nogués, ... Scientific reports 6 (1), 30746, 2016 | 90 | 2016 |
Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus … DS Ghorpade, S Holla, AY Sinha, SK Alagesan, KN Balaji Journal of Biological Chemistry 288 (28), 20592-20606, 2013 | 37 | 2013 |
Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor S Alagesan, MD Griffin Kidney international 85 (4), 730-733, 2014 | 33 | 2014 |
ESAT-6 induced COX-2 expression involves coordinated interplay between PI3K and MAPK signaling K Bansal, S Holla, S Verma-Kumar, P Sharma, KN Balaji Molecular immunology 49 (4), 655-663, 2012 | 30 | 2012 |
Enhancement strategies for mesenchymal stem cells and related therapies S Alagesan, J Brady, D Byrnes, J Fandiño, C Masterson, S McCarthy, ... Stem Cell Research & Therapy 13 (1), 75, 2022 | 23 | 2022 |
Mesenchymal stem cells and a vitamin D receptor agonist additively suppress T helper 17 cells and the related inflammatory response in the kidney MM Duffy, BA McNicholas, DA Monaghan, SA Hanley, JM McMahon, ... American Journal of Physiology-Renal Physiology 307 (12), F1412-F1426, 2014 | 23 | 2014 |
Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion PG Loftus, L Watson, LM Deedigan, E Camarillo‐Retamosa, RM Dwyer, ... International Journal of Cancer 148 (5), 1245-1259, 2021 | 19 | 2021 |
The influence of hypoxia on the differentiation capacities and immunosuppressive properties of clonal mouse mesenchymal stromal cell lines S Prado‐Lòpez, MM Duffy, C Baustian, S Alagesan, SA Hanley, A Stocca, ... Immunology and Cell biology 92 (7), 612-623, 2014 | 18 | 2014 |
Allogeneic mesenchymal stromal cells (MSCs) are of comparable efficacy to syngeneic MSCs for therapeutic revascularization in C57BKSdb/db mice despite the induction of alloantibody A Liew, C Baustian, D Thomas, E Vaughan, C Sanz-Nogués, M Creane, ... Cell transplantation 27 (8), 1210-1221, 2018 | 10 | 2018 |
Comparison of single and repeated dosing of anti-inflammatory human umbilical cord mesenchymal stromal cells in a mouse model of polymicrobial sepsis B Fazekas, S Alagesan, L Watson, O Ng, CM Conroy, C Català, ... Stem cell reviews and reports 18 (4), 1444-1460, 2022 | 9 | 2022 |
Anti‐donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells S Alagesan, C Sanz‐Nogués, X Chen, M Creane, T Ritter, R Ceredig, ... Immunology and Cell Biology 96 (5), 536-548, 2018 | 6 | 2018 |
Differential effects of cytokine versus hypoxic preconditioning of human mesenchymal stromal cells in pulmonary sepsis induced by antimicrobial-resistant Klebsiella pneumoniae D Byrnes, CH Masterson, J Brady, S Alagesan, HE Gonzalez, ... Pharmaceuticals 16 (2), 149, 2023 | 3 | 2023 |
MSCs are protective against ‘second hit’injury during pulmonary sepsis in mechanically ventilated rodents. C Masterson, I Sallent, L Liu, H Gonzalez, S Mc Carthy, D Byrnes, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
Analysis of Memory T-cell Subsets and Their Mitochondrial Status to SARS-CoV2 Spike Peptide Activation in COVID-19 Patient PBMC Samples S Alagesan, HW Ho, C Masterson, E Ribes Martinez, J Laffey, D O'Toole, ... C45. COVID AND ITS CONSEQUENCES: PART II, A5116-A5116, 2023 | | 2023 |
The Effects of the Inflammatory Injury Microenvironment on Mesenchymal Stromal Cell (MSC) Function In Vivo L Liu, J Fandiño Gómez, C Masterson, S Alagesan, M Angel, C Rohde, ... A21. INFECTION, LUNG INJURY, AND SEPSIS FROM MODELS TO TRANSLATION, A1080-A1080, 2023 | | 2023 |
Mesenchymal Stromal Cells Modulate the Immune Cell Response in a Klebsiella Pneumoniae Induced Sepsis Model J Brady, C Masterson, D Byrnes, S Horie, H Gonzalez, S Mccarthy, ... European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
Bone marrow stromal cell transplantation ameliorates cytopenia caused by depletion FAP-α expressing cells E Camarillo-Retamosa, L Watson, P Loftus, S Alagesan, Y O’Donoghue, ... bioRxiv, 2020.11. 23.393959, 2020 | | 2020 |
Immunogenicity of allogeneic mesenchymal stem cells S Alagesan National University of Ireland, Galway, 2016 | | 2016 |